Condition

Acute Myeloid Leukemia Post Cytotoxic Therapy clinical trials and research

• 5Clinical trials
• 5Countries

Newest Acute Myeloid Leukemia Post Cytotoxic Therapy clinical trials

All recruiting trials (5)

• Cedazuridine/decitabine with filgrastim dose escalation after stem cell transplant for children with high-risk AML

  This phase 1 trial will test whether giving the oral combination cedazuridine/decitabine (ASTX727) together with filgrastim is safe and find the highest tolerable dose for children with high-risk acute myeloid leukemia after allogeneic stem cell transplant.

  Recruiting at 14 sites Phase 1 National Cancer Institute (NCI) · Birmingham, Alabama and 14 other locations · NCT07012044

• Testing STX-0712 in patients with advanced blood cancers

  This study is testing a new drug called STX-0712 to see if it can help people with advanced blood cancers like chronic myelomonocytic leukemia and acute myeloid leukemia who have run out of other treatment options.

  Recruiting at 6 sites Phase 1 Solu Therapeutics, Inc · Stanford, California and 6 other locations · NCT06950034

• Screening to match myeloid cancer patients with treatment options

  This study is testing a new way to help people with acute myeloid leukemia or myelodysplastic syndrome find the right treatment options faster by checking their blood and bone marrow for specific markers.

  Recruiting at 345 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 359 other locations · NCT05564390

• Testing new treatments for high-risk acute myeloid leukemia

  This study is testing new treatment combinations for people with high-risk acute myeloid leukemia to see if they can achieve better remission rates than the standard therapy.

  Recruiting at 212 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 226 other locations · NCT05554406

• Screening for pediatric leukemia in children with relapsed or difficult-to-treat cases

  This study is testing how to better screen children and young adults with tough cases of leukemia to see if they qualify for new treatment options.

  Recruiting at 174 sites Phase 1/2 PedAL BCU, LLC · Birmingham, Alabama and 183 other locations · NCT04726241

Related topics

Quick answers

How many Acute Myeloid Leukemia Post Cytotoxic Therapy clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (5 trials), Canada (3 trials), Puerto Rico (3 trials), Australia (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →